Latest Strategy News

Cobre has completed its A$90 million capital raise, including an approximately A$17.7 million second tranche backed by its two largest shareholders and directors. The proceeds will support Sierra Atacama ownership, debt repayment, plant upgrades and exploration in Chile and Botswana.

6K Additive has completed a six-year, US$27.4 million secured loan with the US Export-Import Bank to expand production of critical metal powders in Pennsylvania. The financing gives the company access to project funding through June 2028, but the final interest rate and the expansion’s eventual output remain to be established.

Island Pharmaceuticals has begun GMP production of Galidesivir, with the first 5kg batch targeted for an investigational Ebola treatment program in Uganda. A second batch is intended to support a pivotal Marburg animal study under the FDA’s Animal Rule pathway.

Peter Warren Automotive has completed its acquisition of Wakeling Automotive, but the transaction remains tied to eight dealership divestments required by the ACCC. The deal expands Peter Warren’s dealership portfolio while leaving a significant regulatory obligation outstanding.

Artrya has signed a five-year agreement with Huntsville Hospital Health System, converting the first participant in its SAPPHIRE Study into a commercial customer. The deal carries a minimum contracted value of US$0.5 million for Salix Coronary Anatomy, with further usage-based revenue possible from other modules.

First Au will acquire six exploration licences in Western Australia’s Ora Banda district for A$150,000 upfront, with a further A$500,000 deferred at the seller’s discretion. The deal expands its Riverina tenure but comes with a A$250,000 drilling commitment and remains subject to completion conditions.

Aeris Environmental’s FY2026 annual report pairs international commercial progress with a $5.03 million operating cash drain, $9.22 million in net liabilities and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The company says it will need extended related-party loan terms and further funding while converting its technology and chemicals pipeline into recurring revenue.

Altech Batteries reported a $43.4 million FY2026 loss after abandoning its two major German battery projects, while its CERENERGY subsidiary filed for insolvency and a proposed Malaysian asset sale fell through. The company now faces substantial doubt about its ability to continue as a going concern.

Metrics Real Estate Multi-Strategy Fund units will remain suspended on ASX after the fund failed to lodge its audited financial statements. Reinstatement now depends on the accounts being filed and ASX deciding that trading can resume appropriately.

Pacific Current Group finished FY2026 with no financial debt, A$158 million in cash and a strategic review that could lead to a transaction, a sale or delisting. The balance-sheet repair came alongside lower underlying earnings, a statutory loss and a sharp decline in Victory Park valuations.

Nutritional Growth Solutions has completed its acquisition of Sprout Organic, installing founder Selasi Berdie as CEO and reshaping the group around infant, toddler and children’s nutrition. The deal lifts shares on issue to 964 million, while management targets A$870,000 in annualised savings.

Flagship Minerals has outlined a conceptual 22 million to 40 million tonne tungsten Exploration Target at its Khao Soon project in southern Thailand. The company is now weighing a sale, spin-out or joint venture for the non-core asset, but the target remains well short of a Mineral Resource.